相关实验视频
Updated: Jul 11, 2025

11:11
Canine Intestinal Organoids in a Dual-Chamber Permeable Support System
Published on: March 2, 2022
3.7K
案例报告:在马耳他犬中长期使用欧梅普拉引起的腺息肉
Haemin Lee1, Sanggu Kim2, Dohee Lee1
1Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Chungbuk National University, Cheongju, Republic of Korea.
Frontiers in veterinary science
|November 8, 2023
概括
长期使用像奥梅普拉这样的质子抑制剂可以导致狗的腺息肉. 这份病例报告详细介绍了一只狗,在停止服用奥梅普拉治疗后,其胃息肉消失了.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 长期使用质子抑制剂 (PPI) 与人类的基腺息肉 (FGP) 有关.
- 这种关联在兽医文献中以前没有被记录.
研究的目的:
- 报告与长期服用奥梅普拉相关的狗体腺息肉病例.
- 突出在兽医患者中PPI诱导的FGPs的潜力.
主要方法:
- 检查了一只5岁的马耳他犬,有慢性吐史.
- 进行了腹部超声波,内镜和组织学检查.
- 这只狗曾经接受过长期的奥梅普拉,用于控制脑水症.
主要成果:
- 超声波显示胃壁和的加厚.
- 内镜检查显示了显著的多聚体病变.
- 组织病理学证实了与PPI使用一致的体腺息肉.
- 在停止服用奥梅普拉后,病变消失,通过超声波检查得到确认.
结论:
- 这一案例表明,长期服用奥梅普拉可以诱导狗狗的基腺息肉.
- 停止服用奥梅普拉导致胃多的消失.
- 兽医应该考虑在具有类似临床症状的狗中使用PPI诱导的FGPs.
更多相关视频
相关概念视频
Peptic Ulcer Disease I: Introduction
179
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
179
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
438
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
438
Peptic Ulcer Disease IV: Management
96
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
96
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
458
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
458
Barrett Esophagus-I: Introduction
104
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
104
What is Monogastric Digestion?
71.3K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
71.3K

